Explain monoclonal antibody production
6.3.6· Biology › Biotechnology Applications
WHAT is a monoclonal antibody?
WHY do we need the fusion trick?
| Cell | Desired antibody banata hai? | Hamesha divide karta hai? |
|---|---|---|
| B-lymphocyte | ✅ haan | ❌ ~dinon mein mar jaata hai |
| Myeloma cell | ❌ nahi | ✅ immortal |
| Hybridoma | ✅ haan | ✅ haan |
Toh koi bhi akela parent kaam nahi karta. Hybridoma dono ke best properties inherit karta hai.
HOW is it made — step by step (derive the logic)

Step 1 — Immunise. Mouse ko target antigen inject karo. Yeh step kyun? Isse mouse ka immune system trigger hota hai aur B-cells produce hoti hain jo already us antigen ke against antibodies bana rahi hain. Hum yeh B-cells spleen se harvest karte hain.
Step 2 — Myeloma cells lo. Myeloma (cancerous B-cells) culture karo. Yeh step kyun? Hume "immortality gene package" chahiye. Yeh specially chosen myeloma cells HGPRT⁻ bhi hoti hain (enzyme HGPRT absent hai) — yeh Step 4 ke selection mein crucial ho jaata hai.
Step 3 — Fuse karo. Spleen B-cells + myeloma cells ko ek fusion agent ke saath mix karo (PEG, polyethylene glycol — yeh membranes ko ek saath pighlata hai). Yeh step kyun? Fusion physically do cells ko ek hybrid mein merge karta hai = hybridoma. Lekin fusion random hoti hai, isliye dish mein ab yeh sab hain: unfused B-cells, unfused myeloma, aur hybridomas. Pehle do ko remove karna zaroori hai.
Step 4 — HAT medium mein select karo. Sab kuch HAT medium (Hypoxanthine–Aminopterin–Thymidine) mein grow karo. Yeh step kyun? (clever wali baat)
- Cells DNA do routes se banati hain: de novo pathway aur salvage pathway.
- Aminopterin de novo pathway BLOCK kar deta hai. Toh ek cell sirf salvage pathway use karke survive kar sakti hai, jiske liye enzyme HGPRT chahiye.
- Unfused myeloma cells HGPRT⁻ hain → salvage blocked → mar jaati hain. ✅
- Unfused B-cells normal hain lekin mortal hain → kuch dinon mein waise hi mar jaati hain. ✅
- Hybridomas ko B-cell parent se HGPRT milta hai AUR myeloma parent se immortality → survive karti hain aur divide karti hain. ✅ Toh HAT medium ek filter hai jo sirf hybridomas ko chodta hai.
Step 5 — Screen aur clone karo. Hybridoma cultures test karo taaki woh wala dhundha ja sake jo actually tumhari manpasand antibody bana raha ho, phir itna dilute karo ki har well ek single cell se grow ho (= ek clone). Yeh step kyun? Alag-alag hybridomas alag-alag antibodies banate hain. Hume ek specific epitope ke against clone chahiye — yahi cheez ise monoclonal banati hai.
Step 6 — Mass-produce karo. Chosen clone ko bade bioreactors mein (in vitro) ya mice mein ascites ke roop mein (in vivo) grow karo. Antibody purify karo. Yeh step kyun? Ek immortal clone → unlimited identical antibodies.
Uses (WHY it matters — the 80/20)
Common mistakes
Recall Feynman: explain to a 12-year-old
Socho tumhe ek aisi factory chahiye jo ek EXACT shape ki key stamp kare. Tumhare paas ek worker hai jo exact shape jaanta hai lekin thak jaata hai aur chod deta hai (B-cell). Tumhare paas ek robot hai jo kabhi rukta nahi lekin shape nahi jaanta (cancer cell). Toh tum worker ko robot se chipka dete ho — ab robot-worker shape jaanta hai aur kabhi rukta nahi. Yahi glued combo hybridoma hai, aur yeh hamesha same key banata hai. Phir hum sabko hata dete hain siwaaye is combo ke, ek special khaana (HAT) rakhke jise sirf combo kha sakta hai.
Flashcards
Monoclonal antibody kya hai?
Hybridoma kya hai?
Akela B-lymphocyte mAbs mass-produce karne ke liye kyun use nahi ho sakta?
Akela myeloma cell kyun use nahi ho sakta?
Cells ko merge karne wala fusing agent kaun sa hai?
Antibody-producing B-cells kahan se milti hain?
HAT ka full form kya hai?
HAT medium mein aminopterin kya karta hai?
Salvage pathway se cells survive karne ke liye kaun sa enzyme chahiye?
Unfused myeloma cells HAT mein kyun marti hain?
Unfused B-cells HAT mein kyun marti hain?
Hybridomas HAT mein kyun survive karti hain?
Monoclonal aur polyclonal antibodies mein kya fark hai?
Monoclonal antibodies ke do uses batao.
Connections
- Antibody Structure and Epitopes
- Cell Culture and Bioreactors
- Cancer and Myeloma Cells
- ELISA and Diagnostic Kits
- Immune Response - B and T cells
- Recombinant Therapeutics